清科創業(01945.HK):附屬爲SPAC TechStar發起人
清科創業(01945.HK)公佈,TechStar已向聯交所申請批準TechStarA類普通股及認股權證於聯交所主板上市及買賣。公司全資附屬清科資本有限公司爲TechStar的發起人,亦爲TechStar上市的聯席保薦人。
TechStar發起人爲信銀(香港)資本有限公司、清科管理顧問集團有限公司、清科資本有限公司,李竹、劉偉傑及清科創業董事長兼首席執行官倪正東。
TechStar爲一家特殊目的收購公司,有意專注於識別「新經濟」領域的高增長的特殊目的收購公司併購目標,包括但不限於創新技術、先進製造、醫療保健、生命科學、文娛、消費及新零售、綠色能源和氣候行動行業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.